Kulkarni Samarth's Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Feb 19, 2025
- Accession no.
- 0000950170-25-023385
- Filed
- Feb 19, 2025
- Trade date
- Feb 18-19, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.01M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kulkarni SamarthCIK 0001682019 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Common Shares | MOption exerciseAcquired | +13,250 | – | – | 208,541 | Direct | |
| Feb 18, 2025 | Common Shares | SSaleDisposed | −11,640 | $55.05 | −$640,782 | 196,901 | Direct | |
| Feb 19, 2025 | Common Shares | SSaleDisposed | −6,928 | $52.80 | −$365,798.4 | 189,973 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Common Shares | MOption exerciseDisposed | −13,250 | – | – | 13,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.